Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-06-30Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen nextUnknown journal · 2026-06-28Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-06-13Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-20Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe MushroomsScience Letters · 2026-04-16Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-12Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-27The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.ClinicalTrials.gov · 2026-03-23Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-18The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-06Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-02-28Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot StudyPsychedelic Medicine · 2026-02-02Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”Translational Psychiatry · 2026-01-30Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-01-13Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2025-12-31Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2025-12-31A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.Unknown journal · 2025-12-15Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Unknown journal · 2025-11-05Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-22Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Psilocybin’s effect on human brain synaptic plasticityResearch Square · 2025-10-09Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-18Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.Unknown journal · 2025-09-14Concomitant use of antidepressants and classic psychedelics: A scoping review.Unknown journal · 2025-09-11Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.Asian journal of psychiatry · 2025-07-31The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Unknown journal · 2025-07-17Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 casesNordic Journal of Psychiatry · 2025-07-09Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-17Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-17Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based MediaJournal of Fungi · 2025-06-12Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot studyJournal of Affective Disorders · 2025-06-08Psilocybin’s acute and persistent brain effects: a precision imaging drug trialScientific Data · 2025-06-04Pathway engineering for the biosynthesis of psychedelics.Unknown journal · 2025-05-14Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-15194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-0813. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-03-31Psilocybin Dispensaries and Online Health Claims in CanadaJAMA Network Open · 2025-03-31Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24A qualitative analysis of the psychedelic mushroom come-up and come-downnpj Mental Health Research · 2025-02-06Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trialPLoS ONE · 2025-01-16Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.Unknown journal · 2025-01-06Molecular brain imaging of psychedelic action.International review of neurobiology · 2024-12-31Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.Frontiers in pharmacology · 2024-12-31A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Unknown journal · 2024-12-18The Neurobiological Effect of 5-HT2AR ModulationClinicalTrials.gov · 2024-12-15Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.Unknown journal · 2024-11-04Therapeutic Potential of Psychedelic Compounds for Substance Use DisordersPreprints.org · 2024-10-16Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-13Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Unknown journal · 2024-10-02Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-21Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label StudyResearch Square · 2024-08-22Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.Unknown journal · 2024-08-20Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.Unknown journal · 2024-08-12Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaireJournal of Psychopharmacology · 2024-08-12Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-07-31Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Psilocybin desynchronizes the human brainNature · 2024-07-16Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyClinicalTrials.gov · 2024-07-11Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Unknown journal · 2024-05-30The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-21Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Unknown journal · 2024-03-31The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-22Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-21Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Letter to the Editor: Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?Unknown journal · 2024-01-31A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brainResearch Square · 2024-01-11Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Unknown journal · 2024-01-10Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigsNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31Amygdala response to emotional faces following acute administration of psilocybin in healthy individualsNeuroscience Applied · 2023-12-29Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Unknown journal · 2023-12-14Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybinMedical Writing · 2023-12-10Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.Unknown journal · 2023-11-15Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Unknown journal · 2023-10-10Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Unknown journal · 2023-10-04Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Psilocybin desynchronizes brain networksmedRxiv · 2023-08-23Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.Unknown journal · 2023-08-06A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.Unknown journal · 2023-07-03Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effectsmedRxiv · 2023-07-02Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-17High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-13118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-04The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-04-02Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.Unknown journal · 2023-03-21Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognitionbioRxiv · 2023-02-15Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPsyArXiv · 2023-01-03Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controlsNeuroscience Applied · 2022-12-31A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2022-12-31Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigationComprehensive Psychoneuroendocrinology · 2022-12-05Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary Clinical Trials · 2022-11-01A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.NeuroImage · 2022-10-26Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).BMJ Open · 2022-10-13Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.Frontiers in Psychology · 2022-10-04A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.Unknown journal · 2022-09-30Animal Behavior in Psychedelic Research.Unknown journal · 2022-09-30The use of classic psychedelics among adults: a Danish online survey study.Nordic Journal of Psychiatry · 2022-09-28Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.Unknown journal · 2022-09-11To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and Clinical Psychopharmacology · 2022-08-31Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.Journal of Fungi · 2022-08-17The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Unknown journal · 2022-08-16Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational Psychiatry · 2022-08-10Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-09Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.Journal of psychopharmacology (Oxford, England) · 2022-07-31Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-28Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-12Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-09Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-06-30Sustained effects of single doses of classical psychedelics in humans.Unknown journal · 2022-06-20The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.Systematic reviews · 2022-05-04The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.Journal of midwifery & women's health · 2022-04-30The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Unknown journal · 2022-04-25Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PLoS ONE · 2022-03-15Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic Engineering Communications · 2022-03-11Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in Pharmacology · 2022-03-08Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.Psychopharmacology · 2022-03-01Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.Unknown journal · 2022-02-10Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).ACS Omega · 2022-02-06Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2021-12-31Acute change in functional brain entropy following psilocybin administration in healthy volunteersNeuroscience Applied · 2021-12-31Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.Current topics in behavioral neurosciences · 2021-12-31Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta Crystallographica Section C Structural Chemistry · 2021-12-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effectsmedRxiv · 2021-12-16A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-13P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.Unknown journal · 2021-11-16Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.Unknown journal · 2021-10-07The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.Journal of Holistic Nursing · 2021-09-05Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.European Neuropsychopharmacology · 2021-07-07Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-09Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Unknown journal · 2021-05-17Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signalingThe FASEB Journal · 2021-04-30Have Norwegians tried psilocybin, and do they accept it as a medicine?Journal of Psychedelic Studies · 2021-04-15Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-04Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsbioRxiv · 2021-01-28A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.International Journal of Molecular Sciences · 2021-01-14Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.The International journal on drug policy · 2020-12-31Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in miceBehavioural Brain Research · 2020-12-27Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pigEuropean Neuropsychopharmacology · 2020-12-03Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.Unknown journal · 2020-11-30A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig BrainPreprints.org · 2020-11-29Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybinJournal of Psychopharmacology · 2020-11-03P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-10-31P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-10-31Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07The emerging role of psilocybin and MDMA in the treatment of mental illness.Unknown journal · 2020-09-29Plasma psilocin critically determines behavioral and neurobiological effects of psilocybinNeuropsychopharmacology · 2020-08-24Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybinNeuropsychopharmacology · 2020-05-22Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivativesMetabolic Engineering · 2020-03-25